In a study by Krafl D. et al. published in 2019, using data collected from 144 patients with CDI, at the University Hospital of Vienna, the authors claimed that the ATLAS score is not associated with recurrence of CDI in the 90 days following the first episode, but the level of albumin (a component of the ATLAS score) is positively correlated with the recurrence rate [3]. The gene discussed is ALB; the disease is clostridium difficile infection.